Frequent long-range epigenetic silencing of Protocadherin gene clusters on chromosome 5q31 in Wilms' Tumor

A R Dallosso, A L Hancock, M Szemes, Kim Moorwood, L Chilukamarri, H H Tsai, A Sarkar, J Barasch, R Vuononvirta, C Jones, K Pritchard-Jones, B Royer-Pokora, S B Lee, C Owen, S Malik, Y Feng, M Frank, Andrew Ward, K W Brown, K Malik

Research output: Contribution to journalArticle

106 Citations (Scopus)
85 Downloads (Pure)

Abstract

Wilms' tumour (WT) is a pediatric tumor of the kidney that arises via failure of the fetal developmental program. The absence of identifiable mutations in the majority of WTs suggests the frequent involvement of epigenetic aberrations in WT. We therefore conducted a genome-wide analysis of promoter hypermethylation in WTs and identified hypermethylation at chromosome 5q31 spanning 800 kilobases (kb) and more than 50 genes. The methylated genes all belong to alpha-, beta-, and gamma-protocadherin (PCDH) gene clusters (Human Genome Organization nomenclature PCDHA@, PCDHB@, and PCDHG@, respectively). This demonstrates that long-range epigenetic silencing (LRES) occurs in developmental tumors as well as in adult tumors. Bisulfite polymerase chain reaction analysis showed that PCDH hypermethylation is a frequent event found in all Wilms' tumor subtypes. Hypermethylation is concordant with reduced PCDH expression in tumors. WT precursor lesions showed no PCDH hypermethylation, suggesting that de novo PCDH hypermethylation occurs during malignant progression. Discrete boundaries of the PCDH domain are delimited by abrupt changes in histone modifications; unmethylated genes flanking the LRES are associated with permissive marks which are absent from methylated genes within the domain. Silenced genes are marked with non-permissive histone 3 lysine 9 dimethylation. Expression analysis of embryonic murine kidney and differentiating rat metanephric mesenchymal cells demonstrates that Pcdh expression is developmentally regulated and that Pcdhg@ genes are expressed in blastemal cells. Importantly, we show that PCDHs negatively regulate canonical Wnt signalling, as short-interfering RNA-induced reduction of PCDHG@ encoded proteins leads to elevated beta-catenin protein, increased beta-catenin/T-cell factor (TCF) reporter activity, and induction of Wnt target genes. Conversely, over-expression of PCDHs suppresses beta-catenin/TCF-reporter activity and also inhibits colony formation and growth of cancer cells in soft agar. Thus PCDHs are candidate tumor suppressors that modulate regulatory pathways critical in development and disease, such as canonical Wnt signaling.
Original languageEnglish
Article numbere1000745
Number of pages13
JournalPlos Genetics
Volume5
Issue number11
DOIs
Publication statusPublished - 26 Nov 2009

Fingerprint

Wilms Tumor
cadherins
Multigene Family
multigene family
Epigenomics
epigenetics
tumor
chromosome
Chromosomes
chromosomes
neoplasms
gene
beta Catenin
Genes
TCF Transcription Factors
Neoplasms
genes
Histone Code
histones
Kidney

Cite this

Dallosso, A. R., Hancock, A. L., Szemes, M., Moorwood, K., Chilukamarri, L., Tsai, H. H., ... Malik, K. (2009). Frequent long-range epigenetic silencing of Protocadherin gene clusters on chromosome 5q31 in Wilms' Tumor. Plos Genetics, 5(11), [e1000745]. https://doi.org/10.1371/journal.pgen.1000745

Frequent long-range epigenetic silencing of Protocadherin gene clusters on chromosome 5q31 in Wilms' Tumor. / Dallosso, A R; Hancock, A L; Szemes, M; Moorwood, Kim; Chilukamarri, L; Tsai, H H; Sarkar, A; Barasch, J; Vuononvirta, R; Jones, C; Pritchard-Jones, K; Royer-Pokora, B; Lee, S B; Owen, C; Malik, S; Feng, Y; Frank, M; Ward, Andrew; Brown, K W; Malik, K.

In: Plos Genetics, Vol. 5, No. 11, e1000745, 26.11.2009.

Research output: Contribution to journalArticle

Dallosso, AR, Hancock, AL, Szemes, M, Moorwood, K, Chilukamarri, L, Tsai, HH, Sarkar, A, Barasch, J, Vuononvirta, R, Jones, C, Pritchard-Jones, K, Royer-Pokora, B, Lee, SB, Owen, C, Malik, S, Feng, Y, Frank, M, Ward, A, Brown, KW & Malik, K 2009, 'Frequent long-range epigenetic silencing of Protocadherin gene clusters on chromosome 5q31 in Wilms' Tumor', Plos Genetics, vol. 5, no. 11, e1000745. https://doi.org/10.1371/journal.pgen.1000745
Dallosso, A R ; Hancock, A L ; Szemes, M ; Moorwood, Kim ; Chilukamarri, L ; Tsai, H H ; Sarkar, A ; Barasch, J ; Vuononvirta, R ; Jones, C ; Pritchard-Jones, K ; Royer-Pokora, B ; Lee, S B ; Owen, C ; Malik, S ; Feng, Y ; Frank, M ; Ward, Andrew ; Brown, K W ; Malik, K. / Frequent long-range epigenetic silencing of Protocadherin gene clusters on chromosome 5q31 in Wilms' Tumor. In: Plos Genetics. 2009 ; Vol. 5, No. 11.
@article{f222afa145334d3d973fe12544610204,
title = "Frequent long-range epigenetic silencing of Protocadherin gene clusters on chromosome 5q31 in Wilms' Tumor",
abstract = "Wilms' tumour (WT) is a pediatric tumor of the kidney that arises via failure of the fetal developmental program. The absence of identifiable mutations in the majority of WTs suggests the frequent involvement of epigenetic aberrations in WT. We therefore conducted a genome-wide analysis of promoter hypermethylation in WTs and identified hypermethylation at chromosome 5q31 spanning 800 kilobases (kb) and more than 50 genes. The methylated genes all belong to alpha-, beta-, and gamma-protocadherin (PCDH) gene clusters (Human Genome Organization nomenclature PCDHA@, PCDHB@, and PCDHG@, respectively). This demonstrates that long-range epigenetic silencing (LRES) occurs in developmental tumors as well as in adult tumors. Bisulfite polymerase chain reaction analysis showed that PCDH hypermethylation is a frequent event found in all Wilms' tumor subtypes. Hypermethylation is concordant with reduced PCDH expression in tumors. WT precursor lesions showed no PCDH hypermethylation, suggesting that de novo PCDH hypermethylation occurs during malignant progression. Discrete boundaries of the PCDH domain are delimited by abrupt changes in histone modifications; unmethylated genes flanking the LRES are associated with permissive marks which are absent from methylated genes within the domain. Silenced genes are marked with non-permissive histone 3 lysine 9 dimethylation. Expression analysis of embryonic murine kidney and differentiating rat metanephric mesenchymal cells demonstrates that Pcdh expression is developmentally regulated and that Pcdhg@ genes are expressed in blastemal cells. Importantly, we show that PCDHs negatively regulate canonical Wnt signalling, as short-interfering RNA-induced reduction of PCDHG@ encoded proteins leads to elevated beta-catenin protein, increased beta-catenin/T-cell factor (TCF) reporter activity, and induction of Wnt target genes. Conversely, over-expression of PCDHs suppresses beta-catenin/TCF-reporter activity and also inhibits colony formation and growth of cancer cells in soft agar. Thus PCDHs are candidate tumor suppressors that modulate regulatory pathways critical in development and disease, such as canonical Wnt signaling.",
author = "Dallosso, {A R} and Hancock, {A L} and M Szemes and Kim Moorwood and L Chilukamarri and Tsai, {H H} and A Sarkar and J Barasch and R Vuononvirta and C Jones and K Pritchard-Jones and B Royer-Pokora and Lee, {S B} and C Owen and S Malik and Y Feng and M Frank and Andrew Ward and Brown, {K W} and K Malik",
year = "2009",
month = "11",
day = "26",
doi = "10.1371/journal.pgen.1000745",
language = "English",
volume = "5",
journal = "Plos Genetics",
issn = "1553-7390",
publisher = "Public Library of Science (PLOS)",
number = "11",

}

TY - JOUR

T1 - Frequent long-range epigenetic silencing of Protocadherin gene clusters on chromosome 5q31 in Wilms' Tumor

AU - Dallosso, A R

AU - Hancock, A L

AU - Szemes, M

AU - Moorwood, Kim

AU - Chilukamarri, L

AU - Tsai, H H

AU - Sarkar, A

AU - Barasch, J

AU - Vuononvirta, R

AU - Jones, C

AU - Pritchard-Jones, K

AU - Royer-Pokora, B

AU - Lee, S B

AU - Owen, C

AU - Malik, S

AU - Feng, Y

AU - Frank, M

AU - Ward, Andrew

AU - Brown, K W

AU - Malik, K

PY - 2009/11/26

Y1 - 2009/11/26

N2 - Wilms' tumour (WT) is a pediatric tumor of the kidney that arises via failure of the fetal developmental program. The absence of identifiable mutations in the majority of WTs suggests the frequent involvement of epigenetic aberrations in WT. We therefore conducted a genome-wide analysis of promoter hypermethylation in WTs and identified hypermethylation at chromosome 5q31 spanning 800 kilobases (kb) and more than 50 genes. The methylated genes all belong to alpha-, beta-, and gamma-protocadherin (PCDH) gene clusters (Human Genome Organization nomenclature PCDHA@, PCDHB@, and PCDHG@, respectively). This demonstrates that long-range epigenetic silencing (LRES) occurs in developmental tumors as well as in adult tumors. Bisulfite polymerase chain reaction analysis showed that PCDH hypermethylation is a frequent event found in all Wilms' tumor subtypes. Hypermethylation is concordant with reduced PCDH expression in tumors. WT precursor lesions showed no PCDH hypermethylation, suggesting that de novo PCDH hypermethylation occurs during malignant progression. Discrete boundaries of the PCDH domain are delimited by abrupt changes in histone modifications; unmethylated genes flanking the LRES are associated with permissive marks which are absent from methylated genes within the domain. Silenced genes are marked with non-permissive histone 3 lysine 9 dimethylation. Expression analysis of embryonic murine kidney and differentiating rat metanephric mesenchymal cells demonstrates that Pcdh expression is developmentally regulated and that Pcdhg@ genes are expressed in blastemal cells. Importantly, we show that PCDHs negatively regulate canonical Wnt signalling, as short-interfering RNA-induced reduction of PCDHG@ encoded proteins leads to elevated beta-catenin protein, increased beta-catenin/T-cell factor (TCF) reporter activity, and induction of Wnt target genes. Conversely, over-expression of PCDHs suppresses beta-catenin/TCF-reporter activity and also inhibits colony formation and growth of cancer cells in soft agar. Thus PCDHs are candidate tumor suppressors that modulate regulatory pathways critical in development and disease, such as canonical Wnt signaling.

AB - Wilms' tumour (WT) is a pediatric tumor of the kidney that arises via failure of the fetal developmental program. The absence of identifiable mutations in the majority of WTs suggests the frequent involvement of epigenetic aberrations in WT. We therefore conducted a genome-wide analysis of promoter hypermethylation in WTs and identified hypermethylation at chromosome 5q31 spanning 800 kilobases (kb) and more than 50 genes. The methylated genes all belong to alpha-, beta-, and gamma-protocadherin (PCDH) gene clusters (Human Genome Organization nomenclature PCDHA@, PCDHB@, and PCDHG@, respectively). This demonstrates that long-range epigenetic silencing (LRES) occurs in developmental tumors as well as in adult tumors. Bisulfite polymerase chain reaction analysis showed that PCDH hypermethylation is a frequent event found in all Wilms' tumor subtypes. Hypermethylation is concordant with reduced PCDH expression in tumors. WT precursor lesions showed no PCDH hypermethylation, suggesting that de novo PCDH hypermethylation occurs during malignant progression. Discrete boundaries of the PCDH domain are delimited by abrupt changes in histone modifications; unmethylated genes flanking the LRES are associated with permissive marks which are absent from methylated genes within the domain. Silenced genes are marked with non-permissive histone 3 lysine 9 dimethylation. Expression analysis of embryonic murine kidney and differentiating rat metanephric mesenchymal cells demonstrates that Pcdh expression is developmentally regulated and that Pcdhg@ genes are expressed in blastemal cells. Importantly, we show that PCDHs negatively regulate canonical Wnt signalling, as short-interfering RNA-induced reduction of PCDHG@ encoded proteins leads to elevated beta-catenin protein, increased beta-catenin/T-cell factor (TCF) reporter activity, and induction of Wnt target genes. Conversely, over-expression of PCDHs suppresses beta-catenin/TCF-reporter activity and also inhibits colony formation and growth of cancer cells in soft agar. Thus PCDHs are candidate tumor suppressors that modulate regulatory pathways critical in development and disease, such as canonical Wnt signaling.

UR - http://www.scopus.com/inward/record.url?scp=73649141296&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1371/journal.pgen.1000745

U2 - 10.1371/journal.pgen.1000745

DO - 10.1371/journal.pgen.1000745

M3 - Article

VL - 5

JO - Plos Genetics

JF - Plos Genetics

SN - 1553-7390

IS - 11

M1 - e1000745

ER -